Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Aug 02, 2019 11:34am
72 Views
Post# 29988558

RE:RE:RE:RE:Key takeaways!

RE:RE:RE:RE:Key takeaways!
raptor57 wrote: Hey Prof. Talking of doing it right, I wonder if the HC practice of licencing individual rooms of a facility that is under construction in a piece meal way will cease to happen anymore due to the TRST fiasco. I think back to ACB SKY project and some others that progressed this way? Raptor
Great points Prof.  Carl mentioned their goal is to come down to $1.00 gram cost in the coming months.  Currently they are $1.30.  If they hit that target that is a 23% increase in gross margins.  Take this fact in and absorb it everyone.  23% more on a conservative $600M cannabis sales that is $138M extra gross profit. Couple this with Irwin saying in the next couple of months we will have EU GMP certification. Allowing us to ship to Germany through CC Pharma and also the UK through Althea as they build their patient base. 

Bullboard Posts